A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.

Why are some filings missing?

New filings appear as the SEC updates EDGAR, and older records can vary by availability.

How often is this page updated?

Updates follow new EDGAR submissions and periodic data refreshes.

SEC EDGAR filings, ownership reports, and insider transactions for Hanmi Pharmaceutical Co., Ltd..

Business address: 14, Wiryeseong Daero, Songpa Gu, Seoul, Korea, Republic of, 05545
Top holdings (ownership): APTO
Top holdings (Schedule 13D): APTOF
State of incorporation: Korea, Republic of
Fiscal year end: 31 December

Get insider transactions for this reporting owner

Hanmi Pharmaceutical Co., Ltd. has filed 6 SEC EDGAR filings since 01 Feb 2022

Recent SEC filings for Hanmi Pharmaceutical Co., Ltd. including 3, SCHEDULE 13D/A, SC 13D/A and more.

Form type	Document	Filing	Description	Filing date	Reporting date	File number(s)
3	Open 3 document	View SEC filing for 3		20 Mar 2025	18 Mar 2025	001-32001
SCHEDULE 13D/A	Open SCHEDULE 13D/A document	View SEC filing for SCHEDULE 13D/A		20 Mar 2025
SC 13D/A	Open SC 13D/A document	View SEC filing for SC 13D/A	AMENDMENT NO. 2 TO SCHEDULE 13D	26 Apr 2024
SC 13D/A	Open SC 13D/A document	View SEC filing for SC 13D/A	AMENDMENT NO. 1 TO SCHEDULE 13D	05 Feb 2024
SC 13D	Open SC 13D document	View SEC filing for SC 13D	SCHEDULE 13D	12 Sep 2023
SC 13D	Open SC 13D document	View SEC filing for SC 13D	SCHEDULE 13D	01 Feb 2022

Hanmi Pharmaceutical Co., Ltd. files with the SEC under CIK 0001904921. This page aggregates EDGAR filings and related ownership activity.

What is a CIK?: A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?: New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?: Updates follow new EDGAR submissions and periodic data refreshes.